Approval · Notice of Compliance 27720 · 2022
OXLUMO: Notice of Compliance 27720
Issued March 7, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27720
- Date
- March 7, 2022
- Company
- Alnylam Netherlands B.V.Amsterdam, --, Netherlands
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OXLUMO | 02525755 | Marketed |
Medicinal ingredients
- LUMASIRAN SODIUM 94.5 MG per 0.5ML